DR. JANE S. HANKINS, MD

Plain English
This study looked at two types of therapy—Intraneural Facilitation (INF) and standard physical therapy (PT)—to see which better prevents nerve pain in women receiving chemotherapy for breast and gynecologic cancers. Among 38 women, 32% experienced nerve pain, but both therapies helped keep pain levels mild without needing medication for the first six weeks. The INF therapy showed a significant improvement in numbness after six weeks compared to PT, while PT also reduced other types of pain. Who this helps: This benefits women undergoing chemotherapy for breast and gynecologic cancers.

Plain English
This study looked at how two treatments—intraneural facilitation therapy and a special food elimination plan—help reduce neuropathic pain in patients. The results showed significant improvements in nearly all types of pain reported by patients after treatment, with p-values all less than 0.05, indicating strong evidence that pain decreased. This matters because these findings suggest that combining mechanical therapy with dietary changes can effectively help patients with nerve pain. Who this helps: Patients suffering from neuropathic pain.

Plain English
This study looked at two treatments—Intraneural Facilitation (INF) therapy and exercise—for reducing nerve pain in adults with type 2 diabetes and diabetic peripheral neuropathy (DPN). Both methods significantly reduced pain, but INF therapy also improved different types of pain sensations more broadly than exercise. This matters because it offers options for those who may struggle with exercise. Who this helps: This benefits patients with type 2 diabetes experiencing nerve pain.

Plain English
This research paper discusses how the Brazilian health authorities aim to improve access to hydroxyurea, the only effective treatment for sickle cell disease, by reducing the number of required tests before patients can receive it. The study found that hydroxyurea significantly lowers pain episodes, hospital stays, and the need for blood transfusions, highlighting its importance in managing the disease. By streamlining the process to get this medication, they aim to make it easier for patients to receive the care they need. Who this helps: Patients with sickle cell disease.

Plain English
This study looked at how far cancer patients had to travel to get treatment at a major cancer center and what kind of support they received to help with that travel. On average, patients traveled about 57 miles and spent over an hour getting to the center, and most received about $74 in travel assistance. The findings showed that patients from disadvantaged neighborhoods faced longer travel distances and times, and those who traveled further were more likely to get financial help. Who this helps: This research benefits patients, especially those from disadvantaged communities.

Plain English
This study looked at how fine motor skills, like writing and using tools, relate to academic performance in young people with sickle cell disease (SCD). Researchers found that those with SCD have weaker fine motor skills than expected, which affects their ability to read and do math; for instance, individuals performed significantly poorer in these skills compared to averages for healthy individuals. Understanding this connection is important because improving fine motor skills could boost academic success for these individuals. Who this helps: This helps patients with sickle cell disease and the doctors working with them.

Plain English
This study looked at new gene therapies for sickle cell disease (SCD), a rare genetic illness with few treatment options. Researchers found that while these therapies could offer long-term benefits after just one treatment, ongoing clinical trials have faced delays due to serious safety concerns. It's important to consider not only the high costs of these therapies but also the potential for better health and life expectancy they could provide, especially in communities that currently lack access to effective treatments. Who this helps: Patients with sickle cell disease and those in underserved areas.

Plain English
This study looked at the stress and health issues experienced by healthcare workers during the COVID-19 pandemic. Researchers found that many reported feelings of risk and job insecurity, which led to increased anxiety, depression, weight changes, and fatigue. Understanding these experiences helps create better support systems for healthcare workers during future crises. Who this helps: This helps healthcare workers and the organizations that support them.

Plain English
This study looked at how different medications affect long-term health in patients with heart failure who have a normal heart function (known as HFpEF). It found that beta-blockers reduced the risk of death from any cause by 15% and also lowered cardiovascular deaths compared to a placebo. Additionally, patients taking ACE inhibitors experienced 25% fewer hospitalizations for heart-related issues. This research is important because it highlights effective treatments that can help improve survival and reduce hospital visits for these patients. Who this helps: Patients with heart failure and their doctors.

Plain English
This study looked at how people in Pakistan felt about government policies aimed at stopping the spread of COVID-19. Out of 200 participants, 71% were satisfied with these policies, and 66.5% believed they were effective in fighting the pandemic. Most people, 80%, thought these measures helped reduce the infection rate, showing general support for actions like quarantine. Who this helps: This benefits government officials and public health planners working to improve pandemic responses.

Plain English
This report focuses on a case where a patient had lesions that looked like advanced breast cancer, but they were actually caused by sarcoidosis, a disease that affects many parts of the body. The findings highlight the necessity for doctors to consider different diagnoses when they see signs of cancer, as misdiagnosis can lead to unnecessary treatments. Recognizing this can prevent patients from receiving the wrong care. Who this helps: This helps doctors and patients by improving diagnostic accuracy.

Plain English
This study examined how well two types of PET scans predict how long patients with diffuse large B cell lymphoma (DLBCL) will remain cancer-free after specific chemotherapy treatments. The research involved 92 patients, and it found that the F-Fluorothymidine (iFLT) PET scan was more effective than the F-Fluorodeoxyglucose (iFDG) PET scan. Specifically, 10.4% of patients with a negative iFLT scan progressed in their disease after about 14 months, compared to 56% of those with a positive scan, showing that iFLT is a much better predictor of long-term survival. Who this helps: This information benefits patients with DLBCL and their doctors by improving treatment planning and monitoring.

Plain English
Researchers studied a new transitional year residency program designed for medical students who didn't secure a residency position after graduating. Over three years, this program showed that 90% of participants reported feeling more confident and skilled in their clinical work, which helped them in their career choices. This matters because it provides a much-needed pathway for unmatched students, ensuring they receive support and direction as they prepare for their future medical careers. Who this helps: This helps unmatched medical students and residency program directors.

Plain English
This study looked at how a web-based program called STEP could help teenagers with sickle cell disease learn more about their condition before moving to adult care. Out of 183 young patients invited to use STEP, only 29% participated, but those who completed at least three modules scored significantly better on disease knowledge tests. This improvement in understanding is important because it helps teenagers take better care of themselves as they transition to adult health services. Who this helps: This benefits adolescents with sickle cell disease and their healthcare providers.

Plain English
This study examined a program called Mobile Directly Observed Therapy (Mobile DOT) that helps children with sickle cell disease (SCD) stick to taking their medication, hydroxyurea. After using Mobile DOT, kids' adherence to taking their medication increased from about 62% to 84%, which is significant, and more children (67% compared to 30% before) were taking their medicine as prescribed. This is important because better adherence can lead to improved health outcomes for these patients. Who this helps: This helps children with sickle cell disease and their families.

Plain English
This study looked at how to build and maintain trust between communities, healthcare providers, and academic researchers working together to improve health. Researchers gathered input from 186 people, identifying five key areas that are essential for trust: clear communication, respectful relationships, commitment, sustainability of partnerships, and credibility in problem-solving. Understanding these factors is important because stronger trust can lead to better collaboration and ultimately improve health outcomes in communities. Who this helps: This helps patients, community organizations, and healthcare providers by fostering stronger partnerships for better health solutions.

Plain English
This research looked at various online tools and technology-based programs designed to help people with sickle cell disease manage their health. Out of 16 studies reviewed, most used tools like text messaging or mobile apps to assist with activities such as tracking medications and reporting symptoms. Overall, 94% of these studies found that the participants showed improvements in managing their condition, though the results were not strong enough to draw definitive conclusions. Who this helps: This benefits patients with sickle cell disease and their caregivers by providing tools for better self-management.

Plain English
Researchers studied how a specific genetic variant (UGT1A1 -3279T>G) affects bilirubin levels in children's blood. They found that kids with two copies of this variant had lower bilirubin levels than those with two copies of another variant, while there was no difference when comparing to kids without either variant. This matters because understanding these genetic influences can help in assessing liver function and bilirubin levels in patients. Who this helps: This helps doctors in identifying and managing bilirubin-related conditions in pediatric patients.

Plain English
This study looked at genetic variations in certain genes related to stress and impulsivity in people who suffered severe liver damage from taking too much acetaminophen (a common pain reliever). Researchers found that two specific genetic variants were significantly more common in patients with liver injury: one variant was found with an odds ratio of 1.64 and the other with 1.89, suggesting a connection between these genetic traits and the risk of liver damage. This matters because identifying these genetic factors may help understand why some people are more likely to overdose on acetaminophen, especially in the context of other substance abuse. Who this helps: This research benefits patients at risk for acetaminophen-related liver injury and healthcare providers treating them.

Plain English
This study looked at two types of imaging tests—FLT PET/CT and FDG PET/CT—to see which one was better at predicting how well treatment for diffuse large B-cell lymphoma (DLBCL) was working after two chemotherapy cycles. The researchers found that FLT PET/CT correctly predicted the presence of remaining disease in 91% of cases, while FDG PET/CT methods ranged from only 42% to 46%. This is important because more accurate predictions can help doctors make better treatment decisions for their patients. Who this helps: Patients with diffuse large B-cell lymphoma.

Plain English
This study looked at how genetics can help prescribe codeine safely to children with sickle cell disease, especially after concerns about deaths linked to codeine use. Researchers found that out of 830 patients with sickle cell disease, 75% had genetic results showing that 7.1% were ultra-rapid metabolizers (who process the drug too quickly) and 1.4% were poor metabolizers (who process it too slowly). By using genetic information, doctors could avoid prescribing codeine to those at risk, allowing safe pain management for patients who can benefit from it. Who this helps: This approach helps patients with sickle cell disease by ensuring they receive safe and effective pain treatment.

Plain English
This study looked at how to measure blood flow in the brains of children with sickle cell anemia more effectively using two different methods: manual and semiautomated techniques. Researchers found that both methods provided similar results, with a very close correlation between them (almost 100% agreement). They also discovered that certain blood characteristics, like hemolysis, affected blood flow measurements, which could help in understanding why blood flow varies among these patients. Who this helps: This benefits doctors treating children with sickle cell anemia by providing them with a faster and reliable way to assess brain blood flow.

Plain English
This study looked at a treatment for patients with a type of blood cancer called diffuse large B cell lymphoma (DLBCL) who had either not responded to previous chemotherapy or experienced a relapse. Out of 40 patients treated with a combination of a specific radioactive drug and high-dose chemotherapy, 78% achieved complete remission, and 80% showed a positive response to the treatment. After an average of 6 years, 72% of patients were still alive, and 70% had not seen their cancer return, indicating that this treatment is promising for those facing high-risk situations. Who this helps: This benefits patients with relapsed or high-risk diffuse large B cell lymphoma.

Plain English
This study examined how families talk about sickle cell disease (SCD) during adolescence, focusing on 12 African American families. Researchers found that good communication helped reduce stress and improved medical care for children with SCD. They discovered that parents and affected teens shared more knowledge and talked more easily about the disease than siblings did, highlighting the importance of extended family as a support system. Who this helps: This benefits families of children with sickle cell disease.

Plain English
This study looked at what patients with irritable bowel syndrome (IBS) expect from their healthcare providers and how their actual experiences compare. Out of 1,242 participants, nearly all (96%) wanted providers to give clear information, answer their questions (95.9%), and listen to them (94.4%), but only 38.3% felt they received adequate information in their last visit. Understanding these expectations is crucial because better communication and support from healthcare providers can improve care for IBS patients. Who this helps: Patients with irritable bowel syndrome (IBS).

Plain English
This study looked at blood flow in the brains of children with sickle cell anemia (SCA) using MRI techniques. Researchers found that the blood flow in gray matter was about 87 mL/min/100 g in children treated with hydroxyurea, which is lower than in untreated patients, while white matter showed higher blood flow in normal areas (43 mL/min/100 g) but much lower in abnormal areas (6 mL/min/100 g). This matters because understanding these blood flow patterns helps evaluate how therapies like hydroxyurea affect brain health in SCA and could improve patient care. Who this helps: Patients with sickle cell anemia.

Plain English
Researchers studied how new and existing medications can help people with sickle cell disease (SCD). They found that hydroxycarbamide, a drug used for over 20 years, has shown benefits in both children and adults, but many doctors and patients still do not use it as much as they should. The study highlights the need to improve the acceptance and usage of hydroxycarbamide and explore new drugs that could work better or in combination with it. Who this helps: This benefits patients with sickle cell disease and their healthcare providers.

Plain English
This study looked at how a very low-carbohydrate diet (VLCD) affects people with diarrhea-predominant irritable bowel syndrome (IBS-D). Out of 17 participants, 13 finished the study, and all of them found relief from their symptoms, with 77% feeling better throughout the entire four weeks on the diet. Signs of improvement included a decrease in bowel movements from about 2.6 times to 1.4 times per day and a change from diarrhea to normal stool consistency. This matters because it shows a simple dietary change can significantly enhance the quality of life for those suffering from IBS-D. Who this helps: Patients with diarrhea-predominant irritable bowel syndrome.

Plain English
This study looked at two unusual medical issues, biloma and pneumobilia, in a young patient with sickle cell disease who had severe abdominal pain, yellowing of the skin, and fever. The researchers found that the patient had fluid-filled cysts from bile leaks and gas in the ducts that transport bile, which are not typically seen together but can happen due to complications from sickle cell disease. Understanding these issues is important because they highlight potential severe complications in sickle cell disease that medical professionals need to watch for. Who this helps: This information benefits doctors treating patients with sickle cell disease.

Plain English
This study looked at how patients with irritable bowel syndrome (IBS) prefer to receive educational information about their condition. Out of 1,242 patients surveyed, 68% wanted to learn from their doctor, 62% from the Internet, and 45% from brochures. The findings show that patients feel they need more education than they currently get, highlighting a gap that could improve their management of IBS. Who this helps: This helps patients with IBS who need better information and support about their condition.

Plain English
This study analyzed hydroxyurea capsules from 8 different sources to check their quality and effectiveness for treating sickle cell anemia in children. The results showed that all samples contained the expected amounts of the active ingredient, with variations of no more than 20%, meaning they are reliably effective. This is important because it confirms that generic hydroxyurea can be a safe and affordable treatment option for children with sickle cell anemia, especially in low-resource settings. Who this helps: Patients with sickle cell anemia and their families.

Plain English
This study looked at how patients with severe sickle cell anemia and their families choose between different treatments: hydroxyurea, chronic red cell transfusion, and stem cell transplantation. Out of 30 parents and 7 children surveyed, the most popular choice was hydroxyurea, with 21 parents and 4 children preferring it, while only 5 parents and 1 child chose chronic transfusions and 3 parents and 1 child opted for stem cell transplantation. Understanding these preferences is important because it can help improve future treatments and medical decisions for these patients. Who this helps: This helps patients with severe sickle cell anemia and their families.

Plain English
This study looked at how increasing the levels of the opioid growth factor receptor (OGFr) affects the growth of human pancreatic cancer cells. Researchers found that pancreatic cancer cells with more OGFr grew 47-91% more slowly compared to normal cells, and adding extra opioid growth factor decreased their growth even further by 28-52%. This matters because it suggests that boosting OGFr could be a way to slow down pancreatic cancer growth, potentially leading to new treatment options. Who this helps: This helps patients with pancreatic cancer seeking more effective treatment options.

Plain English
This study explored what people with irritable bowel syndrome (IBS) know about their condition and what information they feel is missing. It involved a survey of 1,242 IBS patients, revealing that many believe misconceptions about IBS, such as 52% thinking it's caused by a lack of digestive enzymes and 47.9% believing it worsens with age. Patients expressed a strong interest in learning about topics like foods to avoid (63.3%) and the causes of IBS (62%), highlighting a significant gap in their knowledge. Who this helps: This information benefits IBS patients looking for better understanding and management of their condition.

Plain English
This study explored how effectively a new ultrasound method, using a continuous infusion of a contrast agent called Definity, detects coronary artery disease when patients are stressed with adenosine. The results showed that the ultrasound method agreed with traditional nuclear imaging in 88% of cases and was able to spot problems in three patients that the nuclear imaging missed; further tests showed these patients had significant artery blockages. This matters because it suggests that the ultrasound technique can find heart issues that other methods might overlook, leading to better diagnosis and treatment. Who this helps: This helps patients with suspected coronary artery disease by providing more accurate diagnoses.

Plain English
This study looked at how albumin, a protein in the blood, helps manage fluid and electrolyte levels in the body. Researchers found that albumin is responsible for about 75% of the pressure that keeps fluids where they belong in the blood vessels, preventing them from leaking out. Understanding this role is important because it can influence treatments for conditions like swelling or dehydration. Who this helps: This benefits patients dealing with fluid balance issues, such as those with kidney problems or heart failure.

Plain English
This study looked at a rare condition in an 81-year-old woman where the bile system had an unusual structure, resulting in problems like abdominal pain and liver issues. Tests showed that instead of the typical bile flow, her gallbladder was filling in a reverse direction through a unique duct. This situation is important because it highlights a previously unreported anatomical issue that can affect how bile drainage works and how such cases should be treated. Who this helps: This helps doctors in diagnosing and treating similar rare conditions in patients.